PIK3C2A and arthritic joint disease: These findings are similar to those reported by Pinal-Fernandez et al. [25] and Rojas-Serrano et al. [9], who described anti-Jo1+ patients display more arthritis, proximal muscle weakness, Raynaud’s phenomenon, and CPK higher levels than those non-anti-Jo1.